ARLINGTON, Va., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Tria Federal today announced the launch of Tria Forge, a secure, serverless generative AI platform that empowers customers to build and deploy AI ...
Phase IIb BID Results Recap In June 2025, MDR-001 BID dosing regimen achieved primary endpoints in the Phase IIb clinical trial, the results demonstrated that MDR-001 achieved a weight loss of up to ...
Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage immuno-oncology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal ...
Boehringer Ingelheim today announced the launch of its new direct-to-consumer platform, “Boehringer Ingelheim Access.” The platform will offer a convenient way for patients in the U.S. to order and ...
Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® and the AYON Body ...
“We are pleased to continue to expand the protection surrounding our bioengineered tissue platform and related novel product candidates,” said Laura Niklason, M.D., Ph.D., Founder and Chief Executive ...
Elicio’s AMP platform, originally developed at the Massachusetts Institute of Technology, has broad potential in the cancer space to advance a number of development initiatives through internal ...
CAN-2409 improved disease-free survival in patients with intermediate-to-high-risk, localized prostate cancer compared to placebo in patients treated with either conventional or moderate ...
Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other ...
Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed company building a long-term strategic treasury of Hyperliquid’s native token, HYPE, today ...
The B-90 blast freezer is engineered to rapidly freeze products, providing speed, efficiency, and reliability for industries where precision matters most. Customers include biopharmaceuticals and cold ...
Quotient Therapeutics, a company pioneering somatic genomics to inform breakthrough medicines, today announced that it has appointed Andrew (Andy) Bayliffe, PhD, as Chief Development Officer. Andy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback